Functional food science and the cardiovascular system

被引:39
作者
Hornstra, G
Barth, CA
Galli, C
Mensink, RP
Mutanen, M
Riemersma, RA
Roberfroid, M
Salminen, K
Vansant, G
Verschuren, PM
机构
[1] Univ Maastricht, Dept Human Biol, Nutr Res Ctr, NL-6200 MD Maastricht, Netherlands
[2] German Inst Human Nutr, Stiftung Offentlichen Rechts, D-14558 Bergholz, Rehbrucke, Germany
[3] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[4] Univ Helsinki, Dept Appl Chem & Microbiol, SF-00014 Helsinki, Finland
[5] Univ Edinburgh, Cardiovasc Res Unit, Edinburgh EW8 9XF, Midlothian, Scotland
[6] Catholic Univ Louvain, Ecole Pharm, B-1200 Brussels, Belgium
[7] Valio Ltd, Res & Dev, SF-00101 Helsinki, Finland
[8] Katholieke Univ Leuven, Lab Expt Geneeskunde Endocrinol, B-3000 Leuven, Belgium
[9] Unilever Res Labs, NL-3133 AT Vlaardingen, Netherlands
关键词
D O I
10.1079/BJN19980107
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Cardiovascular disease has a multifactorial aetiology, as is illustrated by the existence of numerous risk indicators, many of which can be influenced by dietary means. It should be recalled, however, that only after a cause-and-effect relationship has been established between the disease and a given risk indicator (called a risk factor in that case), can modifying this factor be expected to affect disease morbidity and mortality. In this paper, effects of diet on cardiovascular risk are reviewed, with special emphasis on modification of the plasma Lipoprotein profile and of hypertension. In addition, dietary influences on arterial thrombotic processes, immunological interactions, insulin resistance and hyperhomocysteinaemia are discussed. Dietary Lipids are able to affect lipoprotein metabolism in a significant way, thereby modifying the. risk of cardiovascular disease. However, more research is required concerning the possible interactions between the:various dietary fatty acids, and between fatty acids and dietary cholesterol. In addition, more studies are needed with respect to the possible importance of the postprandial state. Although in the aetiology df hypertension the genetic component is definitely stronger than environmental factors, some benefit in terms of the development and coronary complications of atherosclerosis in hypertensive patients can be expected from fatty acids such as ol-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid. This particularly holds for those subjects where the hypertensive mechanism involves the formation of thromboxane Az and/or alpha 1-adrenergic activities. However, large-scale trials are required to test this contention. Certain aspects of blood platelet function, blood coagulability,:and fibrinolytic activity are associated with cardiovascular risk, but causality has been insufficiently proven. Nonetheless, well-designed intervention studies should be initiated to further evaluate such promising dietary components as the various n-3 and n-6 fatty acids and their combination, antioxidants, fibre, etc. for their effect on processes participating in arterial thrombus formation. Long-chain polyenes of the n-3 family and antioxidants can modify the-activity of immunocompetent cells, but we are at an early stage of examining the role pf immune function on the development of atherosclerotic plaques. Actually, there is little, if any, evidence that dietary modulation of immune system responses of cells participating in atherogenesis exerts beneficial effects. Although it seems feasible to modulate insulin sensitivity and subsequent cardiovascular risk factors by decreasing the total amount of dietary fat and increasing the proportion of polyunsaturated fatty acids, additional studies on the efficacy of specific fatty acids, dietary fibre, and low-energy diets, as well as on the mechanisms involved are required to understand the real function of these dietary components. Finally, dietary supplements containing folate and vitamins B-6 and/or B-12 should bd tested for their potential to reduce cardiovascular risk by lowering the plasma level of homocysteine.
引用
收藏
页码:S113 / S146
页数:34
相关论文
共 352 条
[91]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[92]  
Froyland L, 1997, J LIPID RES, V38, P1851
[93]   HOMOCYSTEINE, A RISK FACTOR FOR PREMATURE VASCULAR-DISEASE AND THROMBOSIS, INDUCES TISSUE FACTOR ACTIVITY IN ENDOTHELIAL-CELLS [J].
FRYER, RH ;
WILSON, BD ;
GUBLER, DB ;
FITZGERALD, LA ;
RODGERS, GM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (09) :1327-1333
[94]  
FUJIKAWA M, 1992, IMMUNOLOGY, V75, P330
[95]  
FULTON M, 1988, EUR J CLIN NUTR, V42, P797
[96]   MECHANISMS OF DISEASE - THE PATHOGENESIS OF CORONARY-ARTERY DISEASE AND THE ACUTE CORONARY SYNDROMES .1. [J].
FUSTER, V ;
BADIMON, L ;
BADIMON, JJ ;
CHESEBRO, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :242-250
[97]  
FUSTER V, 1990, CIRCULATION, V82, P47
[98]   IMMUNE-DEFICIENT MICE DEVELOP TYPICAL ATHEROSCLEROTIC FATTY STREAKS WHEN FED AN ATHEROGENIC DIET [J].
FYFE, AI ;
QIAO, JH ;
LUSIS, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2516-2520
[99]   PREVENTING RESTENOSIS WITH FISH OILS FOLLOWING CORONARY ANGIOPLASTY - A METAANALYSIS [J].
GAPINSKI, JP ;
VANRUISWYK, JV ;
HEUDEBERT, GR ;
SCHECTMAN, GS .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) :1595-1601
[100]   INTERFERON-GAMMA INHIBITS SCAVENGER RECEPTOR EXPRESSION AND FOAM CELL-FORMATION IN HUMAN MONOCYTE-DERIVED MACROPHAGES [J].
GENG, YJ ;
HANSSON, GK .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1322-1330